US20230381001A1 - Anti-migration stent - Google Patents
Anti-migration stent Download PDFInfo
- Publication number
- US20230381001A1 US20230381001A1 US18/446,903 US202318446903A US2023381001A1 US 20230381001 A1 US20230381001 A1 US 20230381001A1 US 202318446903 A US202318446903 A US 202318446903A US 2023381001 A1 US2023381001 A1 US 2023381001A1
- Authority
- US
- United States
- Prior art keywords
- stent
- cells
- radially
- wall
- pockets
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000013508 migration Methods 0.000 title description 31
- 238000005192 partition Methods 0.000 claims abstract description 69
- 239000011248 coating agent Substances 0.000 claims abstract description 56
- 238000000576 coating method Methods 0.000 claims abstract description 56
- 239000011800 void material Substances 0.000 claims abstract description 25
- 229910003460 diamond Inorganic materials 0.000 claims description 3
- 239000010432 diamond Substances 0.000 claims description 3
- 239000000463 material Substances 0.000 description 30
- 210000001519 tissue Anatomy 0.000 description 23
- -1 but not limited to Substances 0.000 description 17
- 230000005012 migration Effects 0.000 description 9
- 229920000642 polymer Polymers 0.000 description 9
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 8
- 210000003238 esophagus Anatomy 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- 230000014759 maintenance of location Effects 0.000 description 6
- 229910001000 nickel titanium Inorganic materials 0.000 description 6
- 229920000139 polyethylene terephthalate Polymers 0.000 description 6
- 239000005020 polyethylene terephthalate Substances 0.000 description 6
- 229910001182 Mo alloy Inorganic materials 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 5
- 229920001296 polysiloxane Polymers 0.000 description 5
- 208000031481 Pathologic Constriction Diseases 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 229910001092 metal group alloy Inorganic materials 0.000 description 4
- 229910052697 platinum Inorganic materials 0.000 description 4
- 229920002635 polyurethane Polymers 0.000 description 4
- 239000004814 polyurethane Substances 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 239000004952 Polyamide Substances 0.000 description 3
- 229920002614 Polyether block amide Polymers 0.000 description 3
- 239000004721 Polyphenylene oxide Substances 0.000 description 3
- 210000001072 colon Anatomy 0.000 description 3
- 239000002131 composite material Substances 0.000 description 3
- 230000009975 flexible effect Effects 0.000 description 3
- 239000007943 implant Substances 0.000 description 3
- 150000002739 metals Chemical class 0.000 description 3
- 230000002093 peripheral effect Effects 0.000 description 3
- 229920002647 polyamide Polymers 0.000 description 3
- 239000002861 polymer material Substances 0.000 description 3
- 239000010935 stainless steel Substances 0.000 description 3
- 229910001220 stainless steel Inorganic materials 0.000 description 3
- 230000002792 vascular Effects 0.000 description 3
- 229910000881 Cu alloy Inorganic materials 0.000 description 2
- 239000004812 Fluorinated ethylene propylene Substances 0.000 description 2
- 229920000339 Marlex Polymers 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- 239000004696 Poly ether ether ketone Substances 0.000 description 2
- 239000004697 Polyetherimide Substances 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 239000004642 Polyimide Substances 0.000 description 2
- 239000004734 Polyphenylene sulfide Substances 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- 229910001080 W alloy Inorganic materials 0.000 description 2
- 229910045601 alloy Inorganic materials 0.000 description 2
- 239000000956 alloy Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000003445 biliary tract Anatomy 0.000 description 2
- 239000000788 chromium alloy Substances 0.000 description 2
- 238000005253 cladding Methods 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- YOCUPQPZWBBYIX-UHFFFAOYSA-N copper nickel Chemical compound [Ni].[Cu] YOCUPQPZWBBYIX-UHFFFAOYSA-N 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 229910000701 elgiloys (Co-Cr-Ni Alloy) Inorganic materials 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 229920000840 ethylene tetrafluoroethylene copolymer Polymers 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- DDTIGTPWGISMKL-UHFFFAOYSA-N molybdenum nickel Chemical compound [Ni].[Mo] DDTIGTPWGISMKL-UHFFFAOYSA-N 0.000 description 2
- 229920009441 perflouroethylene propylene Polymers 0.000 description 2
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 2
- 229920001707 polybutylene terephthalate Polymers 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 229920002530 polyetherether ketone Polymers 0.000 description 2
- 229920001601 polyetherimide Polymers 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229920001721 polyimide Polymers 0.000 description 2
- 229920006324 polyoxymethylene Polymers 0.000 description 2
- 229920006380 polyphenylene oxide Polymers 0.000 description 2
- 229920000069 polyphenylene sulfide Polymers 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 2
- 239000004810 polytetrafluoroethylene Substances 0.000 description 2
- 238000004080 punching Methods 0.000 description 2
- 229910001285 shape-memory alloy Inorganic materials 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- 210000001635 urinary tract Anatomy 0.000 description 2
- KHXKESCWFMPTFT-UHFFFAOYSA-N 1,1,1,2,2,3,3-heptafluoro-3-(1,2,2-trifluoroethenoxy)propane Chemical compound FC(F)=C(F)OC(F)(F)C(F)(F)C(F)(F)F KHXKESCWFMPTFT-UHFFFAOYSA-N 0.000 description 1
- 229910000531 Co alloy Inorganic materials 0.000 description 1
- 208000019505 Deglutition disease Diseases 0.000 description 1
- 229920004943 Delrin® Polymers 0.000 description 1
- 229920006055 Durethan® Polymers 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 1
- 208000007217 Esophageal Stenosis Diseases 0.000 description 1
- 229920000219 Ethylene vinyl alcohol Polymers 0.000 description 1
- 206010063560 Excessive granulation tissue Diseases 0.000 description 1
- 229910000640 Fe alloy Inorganic materials 0.000 description 1
- 229920003620 Grilon® Polymers 0.000 description 1
- 229920000271 Kevlar® Polymers 0.000 description 1
- JHWNWJKBPDFINM-UHFFFAOYSA-N Laurolactam Chemical compound O=C1CCCCCCCCCCCN1 JHWNWJKBPDFINM-UHFFFAOYSA-N 0.000 description 1
- 229910001209 Low-carbon steel Inorganic materials 0.000 description 1
- 229910000990 Ni alloy Inorganic materials 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 229920000299 Nylon 12 Polymers 0.000 description 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
- 206010030194 Oesophageal stenosis Diseases 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 229920000265 Polyparaphenylene Polymers 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- QXZUUHYBWMWJHK-UHFFFAOYSA-N [Co].[Ni] Chemical compound [Co].[Ni] QXZUUHYBWMWJHK-UHFFFAOYSA-N 0.000 description 1
- MTHLBYMFGWSRME-UHFFFAOYSA-N [Cr].[Co].[Mo] Chemical compound [Cr].[Co].[Mo] MTHLBYMFGWSRME-UHFFFAOYSA-N 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000003708 ampul Substances 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 229920000249 biocompatible polymer Polymers 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- PRQRQKBNBXPISG-UHFFFAOYSA-N chromium cobalt molybdenum nickel Chemical compound [Cr].[Co].[Ni].[Mo] PRQRQKBNBXPISG-UHFFFAOYSA-N 0.000 description 1
- OGSYQYXYGXIQFH-UHFFFAOYSA-N chromium molybdenum nickel Chemical compound [Cr].[Ni].[Mo] OGSYQYXYGXIQFH-UHFFFAOYSA-N 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 229920006351 engineering plastic Polymers 0.000 description 1
- JBKVHLHDHHXQEQ-UHFFFAOYSA-N epsilon-caprolactam Chemical compound O=C1CCCCCN1 JBKVHLHDHHXQEQ-UHFFFAOYSA-N 0.000 description 1
- 201000004101 esophageal cancer Diseases 0.000 description 1
- QHSJIZLJUFMIFP-UHFFFAOYSA-N ethene;1,1,2,2-tetrafluoroethene Chemical group C=C.FC(F)=C(F)F QHSJIZLJUFMIFP-UHFFFAOYSA-N 0.000 description 1
- HQQADJVZYDDRJT-UHFFFAOYSA-N ethene;prop-1-ene Chemical group C=C.CC=C HQQADJVZYDDRJT-UHFFFAOYSA-N 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 239000005038 ethylene vinyl acetate Substances 0.000 description 1
- 239000004715 ethylene vinyl alcohol Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 238000002594 fluoroscopy Methods 0.000 description 1
- 230000005251 gamma ray Effects 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 210000001126 granulation tissue Anatomy 0.000 description 1
- RZXDTJIXPSCHCI-UHFFFAOYSA-N hexa-1,5-diene-2,5-diol Chemical compound OC(=C)CCC(O)=C RZXDTJIXPSCHCI-UHFFFAOYSA-N 0.000 description 1
- 229920001903 high density polyethylene Polymers 0.000 description 1
- 239000004700 high-density polyethylene Substances 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 229920000554 ionomer Polymers 0.000 description 1
- UGKDIUIOSMUOAW-UHFFFAOYSA-N iron nickel Chemical compound [Fe].[Ni] UGKDIUIOSMUOAW-UHFFFAOYSA-N 0.000 description 1
- 229920000092 linear low density polyethylene Polymers 0.000 description 1
- 239000004707 linear low-density polyethylene Substances 0.000 description 1
- 229920001684 low density polyethylene Polymers 0.000 description 1
- 239000004702 low-density polyethylene Substances 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000002905 metal composite material Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- MOWMLACGTDMJRV-UHFFFAOYSA-N nickel tungsten Chemical compound [Ni].[W] MOWMLACGTDMJRV-UHFFFAOYSA-N 0.000 description 1
- 229910000623 nickel–chromium alloy Inorganic materials 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 230000002572 peristaltic effect Effects 0.000 description 1
- VPRUMANMDWQMNF-UHFFFAOYSA-N phenylethane boronic acid Chemical compound OB(O)CCC1=CC=CC=C1 VPRUMANMDWQMNF-UHFFFAOYSA-N 0.000 description 1
- XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 description 1
- 229920002492 poly(sulfone) Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 239000011112 polyethylene naphthalate Substances 0.000 description 1
- 229940104181 polyflex Drugs 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920002215 polytrimethylene terephthalate Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 239000005033 polyvinylidene chloride Substances 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 229910052715 tantalum Inorganic materials 0.000 description 1
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 1
- MHSKRLJMQQNJNC-UHFFFAOYSA-N terephthalamide Chemical compound NC(=O)C1=CC=C(C(N)=O)C=C1 MHSKRLJMQQNJNC-UHFFFAOYSA-N 0.000 description 1
- 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 210000005166 vasculature Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/848—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents having means for fixation to the vessel wall, e.g. barbs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2002/044—Oesophagi or esophagi or gullets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2002/045—Stomach, intestines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2002/825—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents having longitudinal struts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
- A61F2250/0039—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in diameter
Definitions
- the present disclosure pertains to medical devices, methods for manufacturing medical devices, and uses thereof. More particularly, the present disclosure pertains to an anti-migration stent for implantation in a body lumen, and associated methods.
- Implantable stents are devices that are placed in a body lumen, such as the esophageal tract, the gastrointestinal tract (including the intestine, stomach and the colon), tracheobronchial tract, urinary tract, biliary tract, vascular system, etc. to provide support and to maintain the body lumen open.
- a body lumen such as the esophageal tract, the gastrointestinal tract (including the intestine, stomach and the colon), tracheobronchial tract, urinary tract, biliary tract, vascular system, etc.
- These stents are manufactured by any one of a variety of different manufacturing methods and may be used according to any one of a variety of methods.
- the compressible and flexible properties that assist in stent delivery may also result in a stent that has a tendency to migrate from its originally deployed position.
- stents that are designed to be positioned in the esophageal or gastrointestinal tract may have a tendency to migrate due to peristalsis (i.e., the involuntary constriction and relaxation of the muscles of the esophagus, intestine, and colon which push the contents of the canal therethrough).
- peristalsis i.e., the involuntary constriction and relaxation of the muscles of the esophagus, intestine, and colon which push the contents of the canal therethrough.
- An example medical device may include a stent.
- a stent may comprise an elongated tubular member comprising at least one strut forming a tubular wall having a plurality of cells extending through a thickness of the tubular wall, the elongated tubular member configured to move between a radially collapsed configuration and a radially expanded configuration, a coating disposed on the elongated tubular member and spanning the plurality of cells, the coating forming a pocket within at least some of the plurality of cells and extending radially inward of the tubular wall to define a void, and a partition positioned within at least some of the pockets, each partition extending radially outward from a bottom surface of the pocket and transecting the void.
- At least some of the partitions may extend generally perpendicular to a central longitudinal axis of the elongated tubular member.
- At least some of the partitions may extend generally parallel to a central longitudinal axis of the elongated tubular member.
- At least some of the partitions may extend at an oblique angle relative to a central longitudinal axis of the elongated tubular member.
- a height of the partitions may be approximately equal to a height of the at least one strut having the coating disposed thereon.
- the at least one strut may form a plurality of cross-over points.
- At least some of the partitions may extend between adjacent cross-over points.
- At least some of the partitions may extend from a first side of the pocket to a second side of the pocket in which it is positioned.
- At least one pocket may include two or more partitions.
- the coating may define an entirety of a surface of a lumen extending longitudinally through the stent.
- At least some of the pockets may include an aperture formed therethrough.
- the coating and the partitions may be formed as a single monolithic structure.
- the coating may be disposed over an inner surface and/or an outer surface of the elongated tubular member.
- a stent may comprise an elongated tubular member comprising at least one strut forming a tubular wall having a plurality of cells extending through a thickness of the tubular wall, the elongated tubular member configured to move between a radially collapsed configuration and a radially expanded configuration and a coating disposed on the elongated tubular member and spanning the plurality of cells, the coating forming a pocket within at least some of the plurality of cells and extending radially inward of the tubular wall to define a void.
- the pockets may be pyramidal shaped, with four converging side walls and a base wall intersecting each of the four converging side walls.
- the stent may further comprise a partition positioned within at least some of the pockets, each partition extending radially outward from the base surface of the pocket and transecting the void.
- a stent may comprise an elongated tubular member comprising at least one interwoven filament forming a tubular wall, the at least one interwoven filament forming a plurality of cross-over points and defining a plurality of cells therebetween extending through a thickness of the tubular wall, the elongated tubular member configured to move between a radially collapsed configuration and a radially expanded configuration, a polymer coating disposed on the elongated tubular member, the coating forming a pocket within at least some of the plurality of cells and extending radially inward of the tubular wall to define a void, and a partition formed within at least some of the pockets, each partition extending radially outward from a bottom surface of the pocket and transecting the void between opposing cross-over points of the at least one strut forming the cell in which the pocket is positioned.
- At least some of the partitions may extend generally perpendicular to a central longitudinal axis of the elongated tubular member.
- At least some of the partitions may extend generally parallel to a central longitudinal axis of the elongated tubular member.
- the coating may define an entirety of a surface of a lumen extending longitudinally through the stent.
- the coating and the partitions may be formed as a single monolithic structure.
- a radial outermost extent of the partitions may be located flush with or radially inward of an outer surface of the tubular wall.
- FIG. 1 is a side view of an illustrative stent having an anti-migration system.
- FIG. 2 A is a partial perspective view of the illustrative stent of FIG. 1 .
- FIG. 2 B is a partial side view of the illustrative stent of FIG. 1 .
- FIG. 3 is a cross-sectional view of the illustrative stent of FIG. 1 disposed within a body lumen.
- FIG. 3 A is a cross-sectional view of an alternative variation of the stent of FIG. 1 disposed within a body lumen.
- FIG. 4 is a side view of another illustrative stent having an anti-migration system.
- FIG. 5 A is a partial perspective view of another illustrative stent.
- FIG. 5 B is a partial side view of the illustrative stent of FIG. 4 A .
- FIG. 6 is a cross-sectional view of the illustrative stent of FIG. 4 disposed within a body lumen.
- FIG. 6 A is a cross-sectional view of an alternative variation of the stent of FIG. 4 disposed within a body lumen.
- an endoluminal implant or stent, that can deliver luminal patency in a patient with an esophageal stricture or other medical condition.
- Such stents may be used in patients experiencing dysphagia, sometimes due to esophageal cancer.
- An esophageal stent may allow a patient to maintain nutrition via oral intake during cancer treatment or palliation periods.
- GI gastrointestinal
- Uncoated stents allow the granulation tissue of the esophagus to encompass the stent and effectively grip the wires of the stent.
- tissue ingrowth may help prevent the migration of the stent
- the stent may be difficult to remove. It may be desirable to provide a stent that can deliver luminal patency while minimizing migration of the stent and allowing for removal of the stent.
- stents described herein may be used and sized for use in other locations such as, but not limited to: bodily tissue, bodily organs, vascular lumens, non-vascular lumens and combinations thereof, such as, but not limited to, in the coronary or peripheral vasculature, trachea, bronchi, colon, small intestine, biliary tract, urinary tract, prostate, brain, stomach and the like.
- FIG. 1 illustrates a side view of an illustrative endoluminal implant 10 , such as, but not limited to, a stent.
- the stent 10 may be formed from an elongated tubular member 12 . While the stent 10 is described as generally tubular, it is contemplated that the stent 10 may take any cross-sectional shape desired.
- the stent 10 may have a first, or proximal end 14 , a second, or distal end 16 , and an intermediate region 18 disposed between the first end 14 and the second end 16 .
- the stent 10 may include a lumen 32 extending from a first opening adjacent the first end 14 to a second opening adjacent to the second end 16 to allow for the passage of food, fluids, etc.
- the stent 10 may be expandable from a first radially collapsed configuration (not explicitly shown) to a second radially expanded configuration. In some cases, the stent may be deployed to a configuration between the collapsed configuration and a fully expanded configuration.
- the stent 10 may be structured to extend across a stricture and to apply a radially outward pressure to the stricture in a lumen to open the lumen and allow for the passage of foods, fluids, air, etc.
- the proximal end 14 of the stent 10 may include a plurality of loops 38 .
- the loops 38 may be configured to receive a retrieval tether or suture (not explicitly shown) interwoven therethrough, or otherwise passing through one or more of the loops 38 .
- the retrieval suture may be used to collapse and retrieve the stent 10 , if so desired.
- the retrieval suture may be pulled like a drawstring to radially collapse the proximal end 14 of the stent 10 to facilitate removal of the stent 10 from a body lumen.
- the stent 10 may have a woven structure, fabricated from a number of filaments or struts 36 forming a tubular wall.
- the stent 10 may be knitted or braided with a single filament or strut interwoven with itself and defining open cells 46 extending through the thickness of the tubular wall of the stent 10 .
- the stent 10 may be braided with several filaments or struts interwoven together and defining open cells 46 extending along a length and around the circumference of the tubular wall of the stent 10 .
- the open cells 46 may each define an opening from an outer surface of the tubular wall to an inner surface of the tubular wall (e.g., through a thickness thereof) that is free from the filaments or struts 36 .
- Some exemplary stents including braided filaments include the WallFlex®, WALLSTENT®, and Polyflex® stents, made and distributed by Boston Scientific, Corporation.
- the stent 10 may be knitted, such as the UltraflexTM stents made by Boston Scientific, Corporation.
- the stent 10 may be of a knotted type, such the Precision ColonicTM stents made by Boston Scientific, Corporation.
- the stent 10 may be a laser cut tubular member, such as the EPICTM stents made by Boston Scientific, Corporation.
- a laser cut tubular member may have an open and/or closed cell geometry including one or more interconnected monolithic filaments or struts defining open cells 46 therebetween, with the open cells 46 extending along a length and around the circumference of the tubular wall.
- the open cells 46 may each define an opening from an outer surface of the tubular wall to an inner surface of the tubular wall (e.g., through a thickness thereof) that is free from the interconnected monolithic filaments or struts.
- an inner and/or outer surface of the tubular wall of the stent 10 may be entirely, substantially, or partially, covered with a polymeric covering or coating 40 , as will be described in more detail herein.
- the covering or coating 40 may extend across and/or occlude one or more, or a plurality of the cells 46 defined by the struts or filaments 36 .
- the covering or coating 40 may help reduce food impaction and/or tumor or tissue ingrowth.
- the stent 10 may be a self-expanding stent (SES), although this is not required.
- the stent 10 may include a first end region 20 proximate the proximal end 14 and a second end region 22 proximate the second end 16 .
- the first end region 20 and the second end region 22 may include retention features or anti-migration flared regions 24 , 26 having enlarged diameters relative to the intermediate portion 18 .
- the anti-migration flared regions 24 , 26 which may be positioned adjacent to the first end 14 and the second end 16 of the stent 10 , may be configured to engage an interior portion of the walls of the esophagus or other body lumen.
- the retention features, or flared regions 24 , 26 may have a larger diameter than the cylindrical intermediate region 18 of the stent 10 to prevent the stent 10 from migrating once placed in the esophagus or other body lumen. It is contemplated that the transition 28 , 30 from the cross-sectional area of the intermediate region 18 to the retention features or flared regions 24 , 26 may be gradual, sloped, or occur in an abrupt step-wise manner, as desired.
- the first anti-migration flared region 24 may have a first outer diameter and the second anti-migration flared region 26 may have a second outer diameter. In some instances, the first and second outer diameters may be approximately the same, while in other instances, the first and second outer diameters may be different. In some embodiments, the stent 10 may include only one or none of the anti-migration flared regions 24 , 26 .
- the first end region 20 may include an anti-migration flare 24 while the second end region 22 may have an outer diameter similar to the intermediate region 18 . It is further contemplated that the second end region 22 may include an anti-migration flare 26 while the first end region 20 may have an outer diameter similar to an outer diameter of the intermediate region 18 .
- the stent 10 may have a uniform outer diameter from the first end 14 to the second end 16 .
- the outer diameter of the intermediate region 18 may be in the range of about 15 to 25 millimeters.
- the outer diameter of the anti-migration flares 24 , 26 may be in the range of about 20 to 30 millimeters. It is contemplated that the outer diameter of the stent 10 may be varied to suit the desired application.
- the elongated tubular member of the stent 10 can be made from a number of different materials such as, but not limited to, metals, metal alloys, shape memory alloys and/or polymers, as desired, enabling the stent 10 to be expanded into shape when accurately positioned within the body.
- the material may be selected to enable the stent 10 to be removed with relative ease as well.
- the elongated tubular member of the stent 10 can be formed from alloys such as, but not limited to, nitinol and Elgiloy®.
- the stent 10 may be self-expanding or require an external force to expand the stent 10 .
- composite filaments may be used to make the stent which may include, for example, an outer shell or cladding made of nitinol and a core formed of platinum or other radiopaque material. It is further contemplated the elongated tubular member of the stent 10 may be formed from polymers including, but not limited to, polyethylene terephthalate (PET). In some instances, the filaments of the stent 10 , or portions thereof, may be bioabsorbable or biodegradable, while in other instances the filaments of the stent 10 , or portions thereof, may be biostable.
- PET polyethylene terephthalate
- FIG. 2 A illustrates a partial perspective view of the illustrative stent 10 of FIG. 1
- FIG. 2 B illustrates a partial side view of the illustrative stent 10 of FIG. 1
- the inner and/or outer surface of the tubular wall of the stent 10 may be entirely, substantially, or partially covered with a polymeric covering or coating 40 .
- the coating 40 may be silicone, polyurethane or other flexible polymeric material.
- the coating 40 may be applied such that there is an excess of material or a pocket of material 44 extending between the struts 36 .
- the coating 40 may be loose and extend radially inward from the struts 36 for a radial distance or height 42 to form a void.
- the pocket 44 may be generally pyramidal shaped, with four flat converging (e.g., angled) side walls and a flat bottom or base wall. While the pocket 44 is generally illustrated as having a rhombus cross-sectional shape similar to a diamond shape of the cells 46 formed by the struts 36 , the pocket 44 may take any shape desired.
- the pocket 44 may have a base wall having a generally arcuate shape, such as a generally spherical shape with a spherically concave radially outward facing surface and a spherically convex radially inwardly facing surface.
- the pocket 44 may form a void between a radially outward surface (e.g., a base surface) of the pocket 44 and the circumference of the tubular wall of the stent 10 formed by the struts 36 .
- the pockets 44 may be formed using a mandrel and/or mold.
- a mandrel may be formed having protrusions or recesses of the desired size and shape of the pockets 44 .
- the struts 36 may be wound, braided, woven, or otherwise disposed about the mandrel with the cells of the tubular wall aligned with the protrusions or recesses.
- a sleeve made of, for example, silicone or other polymer material, may be disposed over the mandrel and struts 36 . The sleeve may be heated or otherwise molded to the shape of the mandrel to form the coated stent 10 including the pockets 44 between the struts 36 .
- a polymeric material may be spray or dip coated onto the mandrel and struts 36 such that the polymeric material flows over the protrusions and/or into the recesses of the mandrel.
- the pockets may thereafter be inverted to extend radially inward of the tubular wall of the stent 10 subsequent to removing the stent 10 from the mandrel.
- FIG. 3 illustrates a partial cross-sectional view of the illustrative stent 10 of FIG. 1 deployed in a body lumen 50 having a vessel wall 52 .
- the coating 40 including the pockets 44 may increase frictional forces between the stent 10 and the vessel wall 52 while eliminating or substantially reducing tissue ingrowth around the struts 36 and into the lumen of the stent 10 .
- the coating 40 may be a continuous layer which forms an entirety of the inner surface of the stent 10 .
- the coating 40 may define an entirety of the inner surface of the lumen extending longitudinally through the stent 10 .
- the struts 36 may press into the vessel wall 52 , but, as the struts 36 are fully covered by the coating 40 and the coating 40 spans the cells of the tubular wall of the stent 10 , tissue ingrowth cannot occur around the struts 36 or into the lumen of the stent 10 . Said differently, the tissue cannot grow around and surround the struts 36 . Further, the tissue of the vessel wall 52 may extend into the void defined by the pockets 44 and radially beyond (e.g., inwardly towards the lumen 32 of the stent 10 ) the struts 36 which may help reduce migration rates of the stent 10 . For example, the pockets 44 may provide textures or contours which increase friction. In contrast, a coating 40 that is generally in the same plane as the struts 36 or at the same circumferential position may provide a generally smooth surface which may have lower frictional forces and increased migration rates.
- the volume of tissue that fills the voids defined by the pockets 44 may be manipulated by changing a volume of the pockets 44 . While the pockets 44 are illustrated as having generally uniform dimensions (e.g., are all approximately the same size, shape, and/or volume), the pockets 44 need not all have the same dimensions. For example, some pockets 44 may be larger than others. In some embodiments, one or more of the pockets 44 may include an opening 54 , such as, but not limited to, an aperture or slit to allow for limited tissue ingrowth. Limited tissue ingrowth may further reduce migration of the stent 10 while still allowing for the removal of the stent 10 with little difficulty.
- an opening 54 such as, but not limited to, an aperture or slit to allow for limited tissue ingrowth. Limited tissue ingrowth may further reduce migration of the stent 10 while still allowing for the removal of the stent 10 with little difficulty.
- slits or apertures 54 may be provided to allow for a peripheral vessel to drain into the lumen 50 (for example, but not limited to, at the ampulla to allow bile to flow into the duodenum) or to create a drainage channel in the stent 10 .
- the physician may create the slits or apertures 54 by cutting or punching through the pockets 44 .
- FIG. 3 A illustrates a partial cross-sectional view of a variation of the illustrative stent 10 of FIG. 1 deployed in a body lumen 50 having a vessel wall 52 .
- the pockets 44 may be formed having a generally arcuate shape, such as a generally spherical shape with a spherically concave radially outward facing surface and a spherically convex radially inwardly facing surface.
- FIG. 4 illustrates a side view of another illustrative endoluminal implant 100 , such as, but not limited to, a stent.
- the stent 100 may be similar in form and function to the stent 10 described herein.
- the stent 100 may be formed from an elongated tubular member 112 defining a tubular wall. While the stent 100 is described as generally tubular, it is contemplated that the stent 100 may take any cross-sectional shape desired.
- the stent 100 may have a first, or proximal end 114 , a second, or distal end 116 , and an intermediate region 118 disposed between the first end 114 and the second end 116 .
- the stent 100 may include a lumen 132 extending from a first opening adjacent the first end 114 to a second opening adjacent to the second end 116 to allow for the passage of food, fluids, etc.
- the stent 100 may be expandable from a first radially collapsed configuration (not explicitly shown) to a second radially expanded configuration. In some cases, the stent 100 may be deployed to a configuration between the collapsed configuration and a fully expanded configuration.
- the stent 100 may be structured to extend across a stricture and to apply a radially outward pressure to the stricture in a lumen to open the lumen and allow for the passage of foods, fluids, air, etc.
- the proximal end 114 of the stent 100 may include a plurality of loops 138 .
- the loops 138 may be configured to receive a retrieval tether or suture (not explicitly shown) interwoven therethrough, or otherwise passing through one or more of the loops 138 .
- the retrieval suture may be used to collapse and retrieve the stent 100 , if so desired.
- the retrieval suture may be pulled like a drawstring to radially collapse the proximal end 114 of the stent 100 to facilitate removal of the stent 100 from a body lumen.
- the stent 100 may have a woven structure, fabricated from a number of filaments or struts 136 forming a tubular wall.
- the stent 100 may be knitted or braided with a single filament interwoven with itself and defining open cells 146 extending along a length and around the circumference of the tubular wall of the stent 100 .
- the open cells 146 may each define an opening from an outer surface of the tubular wall to an inner surface of the tubular wall (e.g., through a thickness thereof) that is free from the filaments or struts 136 .
- the stent 100 may be braided with several filaments or struts interwoven together and defining open cells 146 .
- the stent 100 may be knitted. In yet another embodiment, the stent 100 may be of a knotted type. In still another embodiment, the stent 100 may be a laser cut tubular member.
- a laser cut tubular member may have an open and/or closed cell geometry including one or more interconnected monolithic filaments or struts defining open cells 146 therebetween with the open cells 146 extending along a length and around the circumference of the tubular wall.
- the open cells 146 may each define an opening from an outer surface of the tubular wall to an inner surface of the tubular wall (e.g., through a thickness thereof) that is free from the interconnected monolithic filaments or struts.
- an inner and/or outer surface of the tubular wall of the stent 100 may be entirely, substantially, or partially, covered with a polymeric covering or coating 140 , as will be described in more detail herein.
- the covering or coating 140 may extend across and/or occlude one or more, or a plurality of the cells 146 defined by the struts or filaments 136 .
- the covering or coating may help reduce food impaction and/or tumor or tissue ingrowth.
- the stent 100 may be a self-expanding stent (SES), although this is not required.
- the stent 100 may include a first end region 120 proximate the proximal end 114 and a second end region 122 proximate the second end 116 .
- the first end region 120 and the second end region 122 may include retention features or anti-migration flared regions 124 , 126 having enlarged diameters relative to the intermediate portion 118 .
- the anti-migration flared regions 124 , 126 which may be positioned adjacent to the first end 114 and the second end 116 of the stent 10 , may be configured to engage an interior portion of the walls of the esophagus or other body lumen.
- the retention features, or flared regions 124 , 126 may have a larger diameter than the cylindrical intermediate region 118 of the stent 100 to prevent the stent 100 from migrating once placed in the esophagus or other body lumen. It is contemplated that the transition 128 , 130 from the cross-sectional area of the intermediate region 118 to the retention features or flared regions 124 , 126 may be gradual, sloped, or occur in an abrupt step-wise manner, as desired.
- the first anti-migration flared region 124 may have a first outer diameter and the second anti-migration flared region 126 may have a second outer diameter. In some instances, the first and second outer diameters may be approximately the same, while in other instances, the first and second outer diameters may be different. In some embodiments, the stent 100 may include only one or none of the anti-migration flared regions 124 , 126 .
- the first end region 120 may include an anti-migration flare 124 while the second end region 122 may have an outer diameter similar to the intermediate region 118 .
- the second end region 122 may include an anti-migration flare 126 while the first end region 120 may have an outer diameter similar to an outer diameter of the intermediate region 118 .
- the stent 100 may have a uniform outer diameter from the first end 114 to the second end 116 .
- the outer diameter of the intermediate region 118 may be in the range of about 15 to 25 millimeters.
- the outer diameter of the anti-migration flares 124 , 126 may be in the range of about 20 to 30 millimeters. It is contemplated that the outer diameter of the stent 100 may be varied to suit the desired application.
- the elongated tubular member of the stent 100 can be made from a number of different materials such as, but not limited to, metals, metal alloys, shape memory alloys and/or polymers, as desired, enabling the stent 100 to be expanded into shape when accurately positioned within the body.
- the material may be selected to enable the stent 100 to be removed with relative ease as well.
- the elongated tubular member of the stent 100 can be formed from alloys such as, but not limited to, nitinol and Elgiloy®.
- the stent 100 may be self-expanding or require an external force to expand the stent 10 .
- composite filaments may be used to make the stent which may include, for example, an outer shell or cladding made of nitinol and a core formed of platinum or other radiopaque material. It is further contemplated the elongated tubular member of the stent 100 may be formed from polymers including, but not limited to, polyethylene terephthalate (PET). In some instances, the filaments of the stent 10 , or portions thereof, may be bioabsorbable or biodegradable, while in other instances the filaments of the stent 10 , or portions thereof, may be biostable.
- PET polyethylene terephthalate
- FIG. 5 A illustrates a partial perspective view of the illustrative stent 100 of FIG. 4
- FIG. 5 B illustrates a partial side view of the illustrative stent 100 of FIG. 4
- the inner and/or outer surface of the tubular wall of the stent 100 may be entirely, substantially, or partially covered with a polymeric covering or coating 140 .
- the coating 140 may be silicone, polyurethane or other flexible polymeric material.
- the coating 140 may be applied such that there is an excess of material or a pocket of material 144 extending between the struts 136 .
- the coating 140 may be loose and extend radially inward from the struts 136 for a radial distance or height 42 to form a void.
- the pocket 144 may be generally pyramidal shaped, with four flat converging (e.g., angled) side walls and a flat bottom or base wall. While the pocket 144 is generally illustrated as having a rhombus cross-sectional shape similar to a diamond shape of the cells 146 formed by the struts 136 , the pocket 144 may take any shape desired.
- the pocket 144 may have a base wall having a generally arcuate shape, such as a generally spherical shape with a spherically concave radially outward facing surface and a spherically convex radially inwardly facing surface.
- the pocket 144 may form a void between a radially outward surface (e.g., a base surface) of the pocket 144 and the circumference of the tubular wall of the stent 100 formed by the struts 136 .
- the pocket 144 may be divided or split using a partition or wall 148 . It is contemplated that the partition or wall 148 may be formed from the same material as or a different material from the coating 140 , as desired. Each partition or wall 148 may extend across the pocket 144 to transect the void formed by the pocket 144 . For example, each partition or wall 148 may extend entirely across the void from a first side of the pocket 144 to a second side of the pocket 144 in which it is situated and radially outward from a bottom surface thereof.
- each partition or wall 148 may extend entirely across the void from a first side wall of the pocket 144 to a second side wall of the pocket 144 in which it is situated and radially outward from a base wall thereof. In other instances, each partition or wall may extend only across a portion of the void and have one or more ends spaced away from the side walls of the pocket 144 .
- the partitions or walls 148 may be formed as a single monolithic structure with the coating 140 and pockets 144 . In other embodiments, the partitions or walls 148 may be formed as a separate structure and subsequently secured within the pocket 144 using, for example, heat and/or adhesives.
- the partition or wall 148 may be configured to extend between opposing cross-over points 160 of intersecting struts 136 .
- the partition or wall 148 may extend from a first corner to an opposite corner of a pyramidal shaped pocket 144 . This may divide the void defined by the pocket 144 in approximately half.
- the partitions or walls 148 may extend generally orthogonal to a central longitudinal axis 162 (see, for example, FIG. 4 ) of the stent 100 . However, this is not required. In some embodiments, the partitions or walls 148 may extend generally parallel to the central longitudinal axis 162 of the stent 100 .
- the partitions or walls 148 may extend at an oblique angle relative to the central longitudinal axis 162 .
- a first end of the partition or wall 148 may be positioned between two adjacent cross-over points 160 and a second end of the same partition or wall 148 may be positioned between two adjacent cross-over points 160 on an opposite side of the cell 146 .
- the partition or wall 148 may extend from a first corner to an opposite corner of a pyramidal shaped pocket 144 .
- the partitions or walls 148 may be oriented in differing directions.
- some partitions or walls 148 may extend generally perpendicular to the central longitudinal axis 162 , some partitions or walls 148 may extend generally parallel to the central longitudinal axis 162 , and/or some partitions or walls 148 may extend at an oblique angle relative to the longitudinal axis 162 , or any combination thereof. It is further contemplated that the partition or wall 148 may not divide the pocket 144 uniformly. In some embodiments, one or more pockets 144 may include more than one wall 148 , for example.
- the partitions or walls 148 may have first and second opposing side surfaces facing first and second divided regions of the void, respectively.
- the partitions or walls 148 may have a base joined to the base wall of the pocket 144 , and an opposite free end extending radially outward therefrom.
- the pockets 144 and/or partitions or walls 148 may be formed using a mandrel and/or mold.
- a mandrel may be formed having recesses of the desired size and shape of the pockets 144 with protrusions extending outward from the recesses to form the partitions or walls 148 .
- the struts 136 may be wound, braided, woven, or otherwise disposed about the mandrel with the cells of the tubular wall aligned with the recesses.
- a sleeve made of, for example, silicone or other polymer material, may be disposed over the mandrel and struts 136 .
- the sleeve may be heated or otherwise molded to the shape of the mandrel to form the coated stent 100 including the pockets 144 and partitions or walls 148 between the struts 136 .
- a polymeric material may be spray or dip coated onto the mandrel and struts 136 such that the polymeric material flows over the protrusions and/or into the recesses of the mandrel.
- FIG. 6 illustrates a partial cross-sectional view of the illustrative stent 100 of FIG. 4 deployed in a body lumen 150 having a tissue wall 152 .
- the coating 140 including the pockets 144 and partitions or walls 148 may increase frictional forces between the stent 100 and the tissue wall 152 while eliminating or substantially reducing tissue ingrowth around the struts 136 and into the lumen of the stent 100 .
- the coating 140 may be a continuous layer which forms an entirety of the inner surface of the stent 100 .
- the coating 140 may define an entirety of the inner surface of the lumen extending longitudinally through the stent 100 .
- the struts 136 may press into the tissue wall 152 , but, as the struts 136 are fully covered by the coating 140 and the coating spans the cells of the tubular wall of the stent 100 , tissue ingrowth cannot occur around the struts 136 or into the lumen of the stent 100 . Said differently, the tissue cannot grow around and surround the struts 136 . Further, the tissue of the tissue wall 152 may extend into the pockets 144 and, sometimes radially beyond (e.g., inwardly towards the lumen 132 of the stent 100 ) the struts 136 which may help reduce migration rates of the stent 10 . For example, the pockets 144 may provide textures or contours which increase friction.
- a coating 140 that is generally in the same plane as the struts 136 or at the same circumferential position may provide a generally smooth surface which may have lower frictional forces and increased migration rates. It is contemplated that the partitions or walls 148 may increase the surface area of the coating 140 to further increase the friction properties of the stent 100 . It is contemplated that width 164 and/or height 142 of the partition or wall 148 may be varied to increase or decrease the surface area of the coating 140 .
- the stent 100 is generally illustrated as the walls 148 having a height 142 approximately equal to a height of the strut 136 with the coating 140 disposed thereon, the height 142 may be greater than or less than the height of the strut 136 with the coating 140 disposed thereon. It is further contemplated that the partitions or walls 148 each have the same height 142 . It is contemplated that the height 142 may vary uniformly, non-uniformly, in a patterned arrangement or eccentrically about the length and/or circumference of the stent 100 . While the partition or wall 148 is illustrated as having a generally cubic rectangular shape, other shapes may be used, such as, but not limited, hemispherical, conical, pyramidal, etc.
- the volume of tissue that fills the voids of the pockets 144 may be manipulated by changing a volume of the pockets 144 and/or the size of the walls partitions or 148 . While the pockets 144 and partitions or walls 148 are each illustrated as having generally uniform dimensions (e.g., are all approximately the same size, shape, and/or volume), the pockets 144 and/or partitions or walls 148 need not all have the same dimensions. For example, some pockets 144 and/or partitions or walls 148 may be larger than others. In some embodiments, one or more of the pockets 144 may include an opening, such as, but not limited to, an aperture or slit to allow for limited tissue ingrowth.
- Limited tissue ingrowth may further reduce migration of the stent 100 while still allowing for the removal of the stent 100 with little difficulty.
- slits or apertures may be provided to allow for a peripheral vessel to drain into the lumen 150 or to create a drainage channel in the stent 100 .
- the physician may create the slits or apertures by cutting or punching through the pockets 144 .
- FIG. 6 A illustrates a partial cross-sectional view of a variation of the illustrative stent 100 of FIG. 4 deployed in a body lumen 50 having a vessel wall 52 .
- the pockets 144 may be formed having a generally arcuate shape, such as a generally spherical shape with a spherically concave radially outward facing surface and a spherically convex radially inwardly facing surface.
- the partitions or walls 148 may extend radially outward from the spherically concave outward facing surface.
- the stents, delivery systems, and the various components thereof may be made from a metal, metal alloy, polymer (some examples of which are disclosed below), a metal-polymer composite, ceramics, combinations thereof, and the like, or other suitable material.
- suitable metals and metal alloys include stainless steel, such as 304V, 304L, and 316LV stainless steel; mild steel; nickel-titanium alloy such as linear-elastic and/or super-elastic nitinol; other nickel alloys such as nickel-chromium-molybdenum alloys, nickel-copper alloys, nickel-cobalt-chromium-molybdenum alloys, nickel-molybdenum alloys, other nickel-chromium alloys, other nickel-molybdenum alloys, other nickel-cobalt alloys, other nickel-iron alloys, other nickel-copper alloys, other nickel-tungsten or tungsten alloys, and the like; cobalt-chromium alloys; cobalt-chromium
- suitable polymers for the stents or delivery systems may include polytetrafluoroethylene (PTFE), ethylene tetrafluoroethylene (ETFE), fluorinated ethylene propylene (FEP), polyoxymethylene (POM, for example, DELRIN® available from DuPont), polyether block ester, polyurethane (for example, Polyurethane polypropylene (PP), polyvinylchloride (PVC), polyether-ester (for example, ARNITEL® available from DSM Engineering Plastics), ether or ester based copolymers (for example, butylene/poly(alkylene ether) phthalate and/or other polyester elastomers such as HYTREL® available from DuPont), polyamide (for example, DURETHAN® available from Bayer or CRISTAMID® available from Elf Atochem), elastomeric polyamides, block polyamide/ethers, polyether block amide (PEBA, for example available under the trade name PEBAX®),
- portions or all of the stents or delivery systems may also be doped with, made of, or otherwise include a radiopaque material.
- Radiopaque materials are generally understood to be materials which are opaque to RF energy in the wavelength range spanning x-ray to gamma-ray (at thicknesses of ⁇ 0.005′′). These materials are capable of producing a relatively dark image on a fluoroscopy screen relative to the light image that non-radiopaque materials such as tissue produce. This relatively bright image aids the user of the stents or delivery systems in determining its location.
- radiopaque materials can include, but are not limited to, gold, platinum, palladium, tantalum, tungsten alloy, polymer material loaded with a radiopaque filler, and the like. Additionally, other radiopaque marker bands and/or coils may also be incorporated into the design of the stents or delivery systems to achieve the same result.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Veterinary Medicine (AREA)
- Vascular Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Prostheses (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- Materials For Medical Uses (AREA)
Abstract
An illustrative stent includes an elongated tubular member comprising at least one strut or filament forming a tubular wall having a plurality of cells extending through a thickness of the tubular wall. The elongated tubular member may be configured to move between a radially collapsed configuration and a radially expanded configuration. A coating is disposed on the elongated tubular member and spanning the plurality of cells. The coating forms a pocket within at least some of the cells of the plurality of cells and extends radially inward of the tubular wall to define a void. In some instances, a partition or wall is positioned within at least some of the pockets and transects the void.
Description
- The present application is a continuation of U.S. application Ser. No. 17/125,116, filed Dec. 17, 2020, which claims the benefit of and priority to U.S. Provisional Patent Application Ser. No. 62/960,470, filed on Jan. 13, 2020, the disclosures of which are incorporated herein by reference.
- The present disclosure pertains to medical devices, methods for manufacturing medical devices, and uses thereof. More particularly, the present disclosure pertains to an anti-migration stent for implantation in a body lumen, and associated methods.
- Implantable stents are devices that are placed in a body lumen, such as the esophageal tract, the gastrointestinal tract (including the intestine, stomach and the colon), tracheobronchial tract, urinary tract, biliary tract, vascular system, etc. to provide support and to maintain the body lumen open. These stents are manufactured by any one of a variety of different manufacturing methods and may be used according to any one of a variety of methods. Of the known stents, delivery systems, and methods, each has certain advantages and disadvantages. For example, in some stents, the compressible and flexible properties that assist in stent delivery may also result in a stent that has a tendency to migrate from its originally deployed position. For example, stents that are designed to be positioned in the esophageal or gastrointestinal tract may have a tendency to migrate due to peristalsis (i.e., the involuntary constriction and relaxation of the muscles of the esophagus, intestine, and colon which push the contents of the canal therethrough). Thus, there is an ongoing need to provide alternative stents having anti-migration features and associated delivery systems as well as alternative methods for manufacturing and using stents having anti-migration features and associated delivery systems.
- This disclosure provides design, material, manufacturing method, and use alternatives for medical devices. An example medical device may include a stent.
- In a first example, a stent may comprise an elongated tubular member comprising at least one strut forming a tubular wall having a plurality of cells extending through a thickness of the tubular wall, the elongated tubular member configured to move between a radially collapsed configuration and a radially expanded configuration, a coating disposed on the elongated tubular member and spanning the plurality of cells, the coating forming a pocket within at least some of the plurality of cells and extending radially inward of the tubular wall to define a void, and a partition positioned within at least some of the pockets, each partition extending radially outward from a bottom surface of the pocket and transecting the void.
- Alternatively or additionally to any of the examples above, in another example, at least some of the partitions may extend generally perpendicular to a central longitudinal axis of the elongated tubular member.
- Alternatively or additionally to any of the examples above, in another example, at least some of the partitions may extend generally parallel to a central longitudinal axis of the elongated tubular member.
- Alternatively or additionally to any of the examples above, in another example, at least some of the partitions may extend at an oblique angle relative to a central longitudinal axis of the elongated tubular member.
- Alternatively or additionally to any of the examples above, in another example, a height of the partitions may be approximately equal to a height of the at least one strut having the coating disposed thereon.
- Alternatively or additionally to any of the examples above, in another example, the at least one strut may form a plurality of cross-over points.
- Alternatively or additionally to any of the examples above, in another example, at least some of the partitions may extend between adjacent cross-over points.
- Alternatively or additionally to any of the examples above, in another example, at least some of the partitions may extend from a first side of the pocket to a second side of the pocket in which it is positioned.
- Alternatively or additionally to any of the examples above, in another example, at least one pocket may include two or more partitions.
- Alternatively or additionally to any of the examples above, in another example, the coating may define an entirety of a surface of a lumen extending longitudinally through the stent.
- Alternatively or additionally to any of the examples above, in another example, at least some of the pockets may include an aperture formed therethrough.
- Alternatively or additionally to any of the examples above, in another example, the coating and the partitions may be formed as a single monolithic structure.
- Alternatively or additionally to any of the examples above, in another example, the coating may be disposed over an inner surface and/or an outer surface of the elongated tubular member.
- In another example, a stent may comprise an elongated tubular member comprising at least one strut forming a tubular wall having a plurality of cells extending through a thickness of the tubular wall, the elongated tubular member configured to move between a radially collapsed configuration and a radially expanded configuration and a coating disposed on the elongated tubular member and spanning the plurality of cells, the coating forming a pocket within at least some of the plurality of cells and extending radially inward of the tubular wall to define a void. The pockets may be pyramidal shaped, with four converging side walls and a base wall intersecting each of the four converging side walls.
- Alternatively or additionally to any of the examples above, in another example, the stent may further comprise a partition positioned within at least some of the pockets, each partition extending radially outward from the base surface of the pocket and transecting the void.
- In another example, a stent may comprise an elongated tubular member comprising at least one interwoven filament forming a tubular wall, the at least one interwoven filament forming a plurality of cross-over points and defining a plurality of cells therebetween extending through a thickness of the tubular wall, the elongated tubular member configured to move between a radially collapsed configuration and a radially expanded configuration, a polymer coating disposed on the elongated tubular member, the coating forming a pocket within at least some of the plurality of cells and extending radially inward of the tubular wall to define a void, and a partition formed within at least some of the pockets, each partition extending radially outward from a bottom surface of the pocket and transecting the void between opposing cross-over points of the at least one strut forming the cell in which the pocket is positioned.
- Alternatively or additionally to any of the examples above, in another example, at least some of the partitions may extend generally perpendicular to a central longitudinal axis of the elongated tubular member.
- Alternatively or additionally to any of the examples above, in another example, at least some of the partitions may extend generally parallel to a central longitudinal axis of the elongated tubular member.
- Alternatively or additionally to any of the examples above, in another example, the coating may define an entirety of a surface of a lumen extending longitudinally through the stent.
- Alternatively or additionally to any of the examples above, in another example, the coating and the partitions may be formed as a single monolithic structure.
- Alternatively or additionally to any of the examples above, in another example, a radial outermost extent of the partitions may be located flush with or radially inward of an outer surface of the tubular wall.
- The above summary of some embodiments is not intended to describe each disclosed embodiment or every implementation of the present disclosure. The Figures, and Detailed Description, which follow, more particularly exemplify these embodiments.
- The invention may be more completely understood in consideration of the following detailed description of various embodiments in connection with the accompanying drawings, in which:
-
FIG. 1 is a side view of an illustrative stent having an anti-migration system. -
FIG. 2A is a partial perspective view of the illustrative stent ofFIG. 1 . -
FIG. 2B is a partial side view of the illustrative stent ofFIG. 1 . -
FIG. 3 is a cross-sectional view of the illustrative stent ofFIG. 1 disposed within a body lumen. -
FIG. 3A is a cross-sectional view of an alternative variation of the stent ofFIG. 1 disposed within a body lumen. -
FIG. 4 is a side view of another illustrative stent having an anti-migration system. -
FIG. 5A is a partial perspective view of another illustrative stent. -
FIG. 5B is a partial side view of the illustrative stent ofFIG. 4A . -
FIG. 6 is a cross-sectional view of the illustrative stent ofFIG. 4 disposed within a body lumen. -
FIG. 6A is a cross-sectional view of an alternative variation of the stent ofFIG. 4 disposed within a body lumen. - While the disclosure is amenable to various modifications and alternative forms, specifics thereof have been shown by way of example in the drawings and will be described in detail. It should be understood, however, that the intention is not to limit aspects of the invention to the particular embodiments described. On the contrary, the intention is to cover all modifications, equivalents, and alternatives falling within the scope of the invention.
- For the following defined terms, these definitions shall be applied, unless a different definition is given in the claims or elsewhere in this specification.
- All numeric values are herein assumed to be modified by the term “about”, whether or not explicitly indicated. The term “about” generally refers to a range of numbers that one of skill in the art would consider equivalent to the recited value (i.e., having the same function or result). In many instances, the term “about” may be indicative as including numbers that are rounded to the nearest significant figure.
- The recitation of numerical ranges by endpoints includes all numbers within that range (e.g., 1 to 5 includes 1, 1.5, 2, 2.75, 3, 3.80, 4, and 5).
- Although some suitable dimensions ranges and/or values pertaining to various components, features and/or specifications are disclosed, one of skill in the art, incited by the present disclosure, would understand desired dimensions, ranges and/or values may deviate from those expressly disclosed.
- As used in this specification and the appended claims, the singular forms “a”, “an”, and “the” include plural referents unless the content clearly dictates otherwise. As used in this specification and the appended claims, the term “or” is generally employed in its sense including “and/or” unless the content clearly dictates otherwise.
- The following detailed description should be read with reference to the drawings in which similar elements in different drawings are numbered the same. The detailed description and the drawings, which are not necessarily to scale, depict illustrative embodiments and are not intended to limit the scope of the invention. The illustrative embodiments depicted are intended only as exemplary. Selected features of any illustrative embodiment may be incorporated into an additional embodiment unless clearly stated to the contrary.
- In some instances, it may be desirable to provide an endoluminal implant, or stent, that can deliver luminal patency in a patient with an esophageal stricture or other medical condition. Such stents may be used in patients experiencing dysphagia, sometimes due to esophageal cancer. An esophageal stent may allow a patient to maintain nutrition via oral intake during cancer treatment or palliation periods. However, a common complication of gastrointestinal (GI) stents is stent migration due to the peristaltic motion subjected to the stent. Uncoated stents allow the granulation tissue of the esophagus to encompass the stent and effectively grip the wires of the stent. While this tissue ingrowth may help prevent the migration of the stent, the stent may be difficult to remove. It may be desirable to provide a stent that can deliver luminal patency while minimizing migration of the stent and allowing for removal of the stent. While the embodiments disclosed herein are discussed with reference to esophageal stents, it is contemplated that the stents described herein may be used and sized for use in other locations such as, but not limited to: bodily tissue, bodily organs, vascular lumens, non-vascular lumens and combinations thereof, such as, but not limited to, in the coronary or peripheral vasculature, trachea, bronchi, colon, small intestine, biliary tract, urinary tract, prostate, brain, stomach and the like.
-
FIG. 1 illustrates a side view of anillustrative endoluminal implant 10, such as, but not limited to, a stent. In some instances, thestent 10 may be formed from anelongated tubular member 12. While thestent 10 is described as generally tubular, it is contemplated that thestent 10 may take any cross-sectional shape desired. Thestent 10 may have a first, orproximal end 14, a second, ordistal end 16, and anintermediate region 18 disposed between thefirst end 14 and thesecond end 16. Thestent 10 may include alumen 32 extending from a first opening adjacent thefirst end 14 to a second opening adjacent to thesecond end 16 to allow for the passage of food, fluids, etc. - The
stent 10 may be expandable from a first radially collapsed configuration (not explicitly shown) to a second radially expanded configuration. In some cases, the stent may be deployed to a configuration between the collapsed configuration and a fully expanded configuration. Thestent 10 may be structured to extend across a stricture and to apply a radially outward pressure to the stricture in a lumen to open the lumen and allow for the passage of foods, fluids, air, etc. - In some embodiments, the
proximal end 14 of thestent 10 may include a plurality ofloops 38. Theloops 38 may be configured to receive a retrieval tether or suture (not explicitly shown) interwoven therethrough, or otherwise passing through one or more of theloops 38. The retrieval suture may be used to collapse and retrieve thestent 10, if so desired. For example, the retrieval suture may be pulled like a drawstring to radially collapse theproximal end 14 of thestent 10 to facilitate removal of thestent 10 from a body lumen. - The
stent 10 may have a woven structure, fabricated from a number of filaments or struts 36 forming a tubular wall. In some embodiments, thestent 10 may be knitted or braided with a single filament or strut interwoven with itself and definingopen cells 46 extending through the thickness of the tubular wall of thestent 10. In other embodiments, thestent 10 may be braided with several filaments or struts interwoven together and definingopen cells 46 extending along a length and around the circumference of the tubular wall of thestent 10. Theopen cells 46 may each define an opening from an outer surface of the tubular wall to an inner surface of the tubular wall (e.g., through a thickness thereof) that is free from the filaments or struts 36. Some exemplary stents including braided filaments include the WallFlex®, WALLSTENT®, and Polyflex® stents, made and distributed by Boston Scientific, Corporation. In another embodiment, thestent 10 may be knitted, such as the Ultraflex™ stents made by Boston Scientific, Corporation. In yet another embodiment, thestent 10 may be of a knotted type, such the Precision Colonic™ stents made by Boston Scientific, Corporation. In still another embodiment, thestent 10 may be a laser cut tubular member, such as the EPIC™ stents made by Boston Scientific, Corporation. A laser cut tubular member may have an open and/or closed cell geometry including one or more interconnected monolithic filaments or struts definingopen cells 46 therebetween, with theopen cells 46 extending along a length and around the circumference of the tubular wall. Theopen cells 46 may each define an opening from an outer surface of the tubular wall to an inner surface of the tubular wall (e.g., through a thickness thereof) that is free from the interconnected monolithic filaments or struts. In some instances, an inner and/or outer surface of the tubular wall of thestent 10 may be entirely, substantially, or partially, covered with a polymeric covering orcoating 40, as will be described in more detail herein. The covering orcoating 40 may extend across and/or occlude one or more, or a plurality of thecells 46 defined by the struts orfilaments 36. The covering orcoating 40 may help reduce food impaction and/or tumor or tissue ingrowth. In some cases, thestent 10 may be a self-expanding stent (SES), although this is not required. - In some instances, in the radially expanded configuration, the
stent 10 may include afirst end region 20 proximate theproximal end 14 and asecond end region 22 proximate thesecond end 16. In some embodiments, thefirst end region 20 and thesecond end region 22 may include retention features or anti-migration flaredregions intermediate portion 18. The anti-migration flaredregions first end 14 and thesecond end 16 of thestent 10, may be configured to engage an interior portion of the walls of the esophagus or other body lumen. In some embodiments, the retention features, or flaredregions intermediate region 18 of thestent 10 to prevent thestent 10 from migrating once placed in the esophagus or other body lumen. It is contemplated that thetransition intermediate region 18 to the retention features or flaredregions - In some embodiments, the first anti-migration flared
region 24 may have a first outer diameter and the second anti-migration flaredregion 26 may have a second outer diameter. In some instances, the first and second outer diameters may be approximately the same, while in other instances, the first and second outer diameters may be different. In some embodiments, thestent 10 may include only one or none of the anti-migration flaredregions first end region 20 may include ananti-migration flare 24 while thesecond end region 22 may have an outer diameter similar to theintermediate region 18. It is further contemplated that thesecond end region 22 may include ananti-migration flare 26 while thefirst end region 20 may have an outer diameter similar to an outer diameter of theintermediate region 18. In some embodiments, thestent 10 may have a uniform outer diameter from thefirst end 14 to thesecond end 16. In some embodiments, the outer diameter of theintermediate region 18 may be in the range of about 15 to 25 millimeters. The outer diameter of the anti-migration flares 24, 26 may be in the range of about 20 to 30 millimeters. It is contemplated that the outer diameter of thestent 10 may be varied to suit the desired application. - It is contemplated that the elongated tubular member of the
stent 10 can be made from a number of different materials such as, but not limited to, metals, metal alloys, shape memory alloys and/or polymers, as desired, enabling thestent 10 to be expanded into shape when accurately positioned within the body. In some instances, the material may be selected to enable thestent 10 to be removed with relative ease as well. For example, the elongated tubular member of thestent 10 can be formed from alloys such as, but not limited to, nitinol and Elgiloy®. Depending on the material selected for construction, thestent 10 may be self-expanding or require an external force to expand thestent 10. In some embodiments, composite filaments may be used to make the stent which may include, for example, an outer shell or cladding made of nitinol and a core formed of platinum or other radiopaque material. It is further contemplated the elongated tubular member of thestent 10 may be formed from polymers including, but not limited to, polyethylene terephthalate (PET). In some instances, the filaments of thestent 10, or portions thereof, may be bioabsorbable or biodegradable, while in other instances the filaments of thestent 10, or portions thereof, may be biostable. -
FIG. 2A illustrates a partial perspective view of theillustrative stent 10 ofFIG. 1 andFIG. 2B illustrates a partial side view of theillustrative stent 10 ofFIG. 1 . As described above, the inner and/or outer surface of the tubular wall of thestent 10 may be entirely, substantially, or partially covered with a polymeric covering orcoating 40. Thecoating 40 may be silicone, polyurethane or other flexible polymeric material. Thecoating 40 may be applied such that there is an excess of material or a pocket ofmaterial 44 extending between thestruts 36. For example, instead of extending generally taut in the same plane as thestruts 36, thecoating 40 may be loose and extend radially inward from thestruts 36 for a radial distance orheight 42 to form a void. In some instances, thepocket 44 may be generally pyramidal shaped, with four flat converging (e.g., angled) side walls and a flat bottom or base wall. While thepocket 44 is generally illustrated as having a rhombus cross-sectional shape similar to a diamond shape of thecells 46 formed by thestruts 36, thepocket 44 may take any shape desired. For instance, in some instances thepocket 44 may have a base wall having a generally arcuate shape, such as a generally spherical shape with a spherically concave radially outward facing surface and a spherically convex radially inwardly facing surface. Thepocket 44 may form a void between a radially outward surface (e.g., a base surface) of thepocket 44 and the circumference of the tubular wall of thestent 10 formed by thestruts 36. - In some instances, the
pockets 44 may be formed using a mandrel and/or mold. For example, a mandrel may be formed having protrusions or recesses of the desired size and shape of thepockets 44. Thestruts 36 may be wound, braided, woven, or otherwise disposed about the mandrel with the cells of the tubular wall aligned with the protrusions or recesses. A sleeve made of, for example, silicone or other polymer material, may be disposed over the mandrel and struts 36. The sleeve may be heated or otherwise molded to the shape of the mandrel to form thecoated stent 10 including thepockets 44 between thestruts 36. Alternatively, a polymeric material may be spray or dip coated onto the mandrel and struts 36 such that the polymeric material flows over the protrusions and/or into the recesses of the mandrel. In instances that the pockets are formed by protrusions of the mandrel, the pockets may thereafter be inverted to extend radially inward of the tubular wall of thestent 10 subsequent to removing thestent 10 from the mandrel. -
FIG. 3 illustrates a partial cross-sectional view of theillustrative stent 10 ofFIG. 1 deployed in abody lumen 50 having avessel wall 52. It is contemplated that thecoating 40 including thepockets 44 may increase frictional forces between thestent 10 and thevessel wall 52 while eliminating or substantially reducing tissue ingrowth around thestruts 36 and into the lumen of thestent 10. For example, thecoating 40 may be a continuous layer which forms an entirety of the inner surface of thestent 10. In other words, thecoating 40 may define an entirety of the inner surface of the lumen extending longitudinally through thestent 10. Thus, thestruts 36 may press into thevessel wall 52, but, as thestruts 36 are fully covered by thecoating 40 and thecoating 40 spans the cells of the tubular wall of thestent 10, tissue ingrowth cannot occur around thestruts 36 or into the lumen of thestent 10. Said differently, the tissue cannot grow around and surround thestruts 36. Further, the tissue of thevessel wall 52 may extend into the void defined by thepockets 44 and radially beyond (e.g., inwardly towards thelumen 32 of the stent 10) thestruts 36 which may help reduce migration rates of thestent 10. For example, thepockets 44 may provide textures or contours which increase friction. In contrast, acoating 40 that is generally in the same plane as thestruts 36 or at the same circumferential position may provide a generally smooth surface which may have lower frictional forces and increased migration rates. - It is contemplated that the volume of tissue that fills the voids defined by the
pockets 44 may be manipulated by changing a volume of thepockets 44. While thepockets 44 are illustrated as having generally uniform dimensions (e.g., are all approximately the same size, shape, and/or volume), thepockets 44 need not all have the same dimensions. For example, somepockets 44 may be larger than others. In some embodiments, one or more of thepockets 44 may include anopening 54, such as, but not limited to, an aperture or slit to allow for limited tissue ingrowth. Limited tissue ingrowth may further reduce migration of thestent 10 while still allowing for the removal of thestent 10 with little difficulty. Alternatively, or additionally, slits orapertures 54 may be provided to allow for a peripheral vessel to drain into the lumen 50 (for example, but not limited to, at the ampulla to allow bile to flow into the duodenum) or to create a drainage channel in thestent 10. In some cases, the physician may create the slits orapertures 54 by cutting or punching through thepockets 44. -
FIG. 3A illustrates a partial cross-sectional view of a variation of theillustrative stent 10 ofFIG. 1 deployed in abody lumen 50 having avessel wall 52. InFIG. 3A , it can be seen that thepockets 44 may be formed having a generally arcuate shape, such as a generally spherical shape with a spherically concave radially outward facing surface and a spherically convex radially inwardly facing surface. -
FIG. 4 illustrates a side view of anotherillustrative endoluminal implant 100, such as, but not limited to, a stent. Thestent 100 may be similar in form and function to thestent 10 described herein. In some instances, thestent 100 may be formed from anelongated tubular member 112 defining a tubular wall. While thestent 100 is described as generally tubular, it is contemplated that thestent 100 may take any cross-sectional shape desired. Thestent 100 may have a first, orproximal end 114, a second, ordistal end 116, and anintermediate region 118 disposed between thefirst end 114 and thesecond end 116. Thestent 100 may include alumen 132 extending from a first opening adjacent thefirst end 114 to a second opening adjacent to thesecond end 116 to allow for the passage of food, fluids, etc. - The
stent 100 may be expandable from a first radially collapsed configuration (not explicitly shown) to a second radially expanded configuration. In some cases, thestent 100 may be deployed to a configuration between the collapsed configuration and a fully expanded configuration. Thestent 100 may be structured to extend across a stricture and to apply a radially outward pressure to the stricture in a lumen to open the lumen and allow for the passage of foods, fluids, air, etc. - In some embodiments, the
proximal end 114 of thestent 100 may include a plurality ofloops 138. Theloops 138 may be configured to receive a retrieval tether or suture (not explicitly shown) interwoven therethrough, or otherwise passing through one or more of theloops 138. The retrieval suture may be used to collapse and retrieve thestent 100, if so desired. For example, the retrieval suture may be pulled like a drawstring to radially collapse theproximal end 114 of thestent 100 to facilitate removal of thestent 100 from a body lumen. - The
stent 100 may have a woven structure, fabricated from a number of filaments or struts 136 forming a tubular wall. In some embodiments, thestent 100 may be knitted or braided with a single filament interwoven with itself and definingopen cells 146 extending along a length and around the circumference of the tubular wall of thestent 100. Theopen cells 146 may each define an opening from an outer surface of the tubular wall to an inner surface of the tubular wall (e.g., through a thickness thereof) that is free from the filaments or struts 136. In other embodiments, thestent 100 may be braided with several filaments or struts interwoven together and definingopen cells 146. In another embodiment, thestent 100 may be knitted. In yet another embodiment, thestent 100 may be of a knotted type. In still another embodiment, thestent 100 may be a laser cut tubular member. A laser cut tubular member may have an open and/or closed cell geometry including one or more interconnected monolithic filaments or struts definingopen cells 146 therebetween with theopen cells 146 extending along a length and around the circumference of the tubular wall. Theopen cells 146 may each define an opening from an outer surface of the tubular wall to an inner surface of the tubular wall (e.g., through a thickness thereof) that is free from the interconnected monolithic filaments or struts. In some instances, an inner and/or outer surface of the tubular wall of thestent 100 may be entirely, substantially, or partially, covered with a polymeric covering orcoating 140, as will be described in more detail herein. The covering orcoating 140 may extend across and/or occlude one or more, or a plurality of thecells 146 defined by the struts orfilaments 136. The covering or coating may help reduce food impaction and/or tumor or tissue ingrowth. In some cases, thestent 100 may be a self-expanding stent (SES), although this is not required. - In some instances, in the radially expanded configuration, the
stent 100 may include afirst end region 120 proximate theproximal end 114 and asecond end region 122 proximate thesecond end 116. In some embodiments, thefirst end region 120 and thesecond end region 122 may include retention features or anti-migration flaredregions intermediate portion 118. The anti-migration flaredregions first end 114 and thesecond end 116 of thestent 10, may be configured to engage an interior portion of the walls of the esophagus or other body lumen. In some embodiments, the retention features, or flaredregions intermediate region 118 of thestent 100 to prevent thestent 100 from migrating once placed in the esophagus or other body lumen. It is contemplated that thetransition intermediate region 118 to the retention features or flaredregions - In some embodiments, the first anti-migration flared
region 124 may have a first outer diameter and the second anti-migration flaredregion 126 may have a second outer diameter. In some instances, the first and second outer diameters may be approximately the same, while in other instances, the first and second outer diameters may be different. In some embodiments, thestent 100 may include only one or none of the anti-migration flaredregions first end region 120 may include ananti-migration flare 124 while thesecond end region 122 may have an outer diameter similar to theintermediate region 118. It is further contemplated that thesecond end region 122 may include ananti-migration flare 126 while thefirst end region 120 may have an outer diameter similar to an outer diameter of theintermediate region 118. In some embodiments, thestent 100 may have a uniform outer diameter from thefirst end 114 to thesecond end 116. In some embodiments, the outer diameter of theintermediate region 118 may be in the range of about 15 to 25 millimeters. The outer diameter of the anti-migration flares 124, 126 may be in the range of about 20 to 30 millimeters. It is contemplated that the outer diameter of thestent 100 may be varied to suit the desired application. - It is contemplated that the elongated tubular member of the
stent 100 can be made from a number of different materials such as, but not limited to, metals, metal alloys, shape memory alloys and/or polymers, as desired, enabling thestent 100 to be expanded into shape when accurately positioned within the body. In some instances, the material may be selected to enable thestent 100 to be removed with relative ease as well. For example, the elongated tubular member of thestent 100 can be formed from alloys such as, but not limited to, nitinol and Elgiloy®. Depending on the material selected for construction, thestent 100 may be self-expanding or require an external force to expand thestent 10. In some embodiments, composite filaments may be used to make the stent which may include, for example, an outer shell or cladding made of nitinol and a core formed of platinum or other radiopaque material. It is further contemplated the elongated tubular member of thestent 100 may be formed from polymers including, but not limited to, polyethylene terephthalate (PET). In some instances, the filaments of thestent 10, or portions thereof, may be bioabsorbable or biodegradable, while in other instances the filaments of thestent 10, or portions thereof, may be biostable. -
FIG. 5A illustrates a partial perspective view of theillustrative stent 100 ofFIG. 4 andFIG. 5B illustrates a partial side view of theillustrative stent 100 ofFIG. 4 . As described above, the inner and/or outer surface of the tubular wall of thestent 100 may be entirely, substantially, or partially covered with a polymeric covering orcoating 140. Thecoating 140 may be silicone, polyurethane or other flexible polymeric material. Thecoating 140 may be applied such that there is an excess of material or a pocket ofmaterial 144 extending between thestruts 136. For example, instead of extending generally taut in the same plane as thestruts 136, thecoating 140 may be loose and extend radially inward from thestruts 136 for a radial distance orheight 42 to form a void. In some instances, thepocket 144 may be generally pyramidal shaped, with four flat converging (e.g., angled) side walls and a flat bottom or base wall. While thepocket 144 is generally illustrated as having a rhombus cross-sectional shape similar to a diamond shape of thecells 146 formed by thestruts 136, thepocket 144 may take any shape desired. For instance, in some instances thepocket 144 may have a base wall having a generally arcuate shape, such as a generally spherical shape with a spherically concave radially outward facing surface and a spherically convex radially inwardly facing surface. Thepocket 144 may form a void between a radially outward surface (e.g., a base surface) of thepocket 144 and the circumference of the tubular wall of thestent 100 formed by thestruts 136. - In some cases, the
pocket 144 may be divided or split using a partition orwall 148. It is contemplated that the partition orwall 148 may be formed from the same material as or a different material from thecoating 140, as desired. Each partition orwall 148 may extend across thepocket 144 to transect the void formed by thepocket 144. For example, each partition orwall 148 may extend entirely across the void from a first side of thepocket 144 to a second side of thepocket 144 in which it is situated and radially outward from a bottom surface thereof. For example, each partition orwall 148 may extend entirely across the void from a first side wall of thepocket 144 to a second side wall of thepocket 144 in which it is situated and radially outward from a base wall thereof. In other instances, each partition or wall may extend only across a portion of the void and have one or more ends spaced away from the side walls of thepocket 144. The partitions orwalls 148 may be formed as a single monolithic structure with thecoating 140 and pockets 144. In other embodiments, the partitions orwalls 148 may be formed as a separate structure and subsequently secured within thepocket 144 using, for example, heat and/or adhesives. In some cases, the partition orwall 148 may be configured to extend between opposingcross-over points 160 of intersecting struts 136. For instance, in some instances, the partition orwall 148 may extend from a first corner to an opposite corner of a pyramidal shapedpocket 144. This may divide the void defined by thepocket 144 in approximately half. In some cases, the partitions orwalls 148 may extend generally orthogonal to a central longitudinal axis 162 (see, for example,FIG. 4 ) of thestent 100. However, this is not required. In some embodiments, the partitions orwalls 148 may extend generally parallel to the centrallongitudinal axis 162 of thestent 100. In yet other embodiments, the partitions orwalls 148 may extend at an oblique angle relative to the centrallongitudinal axis 162. For example, a first end of the partition orwall 148 may be positioned between two adjacent cross-over points 160 and a second end of the same partition orwall 148 may be positioned between two adjacent cross-over points 160 on an opposite side of thecell 146. Thus, the partition orwall 148 may extend from a first corner to an opposite corner of a pyramidal shapedpocket 144. In some cases, the partitions orwalls 148 may be oriented in differing directions. For example, some partitions orwalls 148 may extend generally perpendicular to the centrallongitudinal axis 162, some partitions orwalls 148 may extend generally parallel to the centrallongitudinal axis 162, and/or some partitions orwalls 148 may extend at an oblique angle relative to thelongitudinal axis 162, or any combination thereof. It is further contemplated that the partition orwall 148 may not divide thepocket 144 uniformly. In some embodiments, one ormore pockets 144 may include more than onewall 148, for example. - The partitions or
walls 148 may have first and second opposing side surfaces facing first and second divided regions of the void, respectively. The partitions orwalls 148 may have a base joined to the base wall of thepocket 144, and an opposite free end extending radially outward therefrom. - In some instances, the
pockets 144 and/or partitions orwalls 148 may be formed using a mandrel and/or mold. For example, a mandrel may be formed having recesses of the desired size and shape of thepockets 144 with protrusions extending outward from the recesses to form the partitions orwalls 148. Thestruts 136 may be wound, braided, woven, or otherwise disposed about the mandrel with the cells of the tubular wall aligned with the recesses. A sleeve made of, for example, silicone or other polymer material, may be disposed over the mandrel and struts 136. The sleeve may be heated or otherwise molded to the shape of the mandrel to form thecoated stent 100 including thepockets 144 and partitions orwalls 148 between thestruts 136. Alternatively, a polymeric material may be spray or dip coated onto the mandrel and struts 136 such that the polymeric material flows over the protrusions and/or into the recesses of the mandrel. -
FIG. 6 illustrates a partial cross-sectional view of theillustrative stent 100 ofFIG. 4 deployed in abody lumen 150 having atissue wall 152. It is contemplated that thecoating 140 including thepockets 144 and partitions orwalls 148 may increase frictional forces between thestent 100 and thetissue wall 152 while eliminating or substantially reducing tissue ingrowth around thestruts 136 and into the lumen of thestent 100. For example, thecoating 140 may be a continuous layer which forms an entirety of the inner surface of thestent 100. In other words, thecoating 140 may define an entirety of the inner surface of the lumen extending longitudinally through thestent 100. Thus, thestruts 136 may press into thetissue wall 152, but, as thestruts 136 are fully covered by thecoating 140 and the coating spans the cells of the tubular wall of thestent 100, tissue ingrowth cannot occur around thestruts 136 or into the lumen of thestent 100. Said differently, the tissue cannot grow around and surround thestruts 136. Further, the tissue of thetissue wall 152 may extend into thepockets 144 and, sometimes radially beyond (e.g., inwardly towards thelumen 132 of the stent 100) thestruts 136 which may help reduce migration rates of thestent 10. For example, thepockets 144 may provide textures or contours which increase friction. In contrast, acoating 140 that is generally in the same plane as thestruts 136 or at the same circumferential position may provide a generally smooth surface which may have lower frictional forces and increased migration rates. It is contemplated that the partitions orwalls 148 may increase the surface area of thecoating 140 to further increase the friction properties of thestent 100. It is contemplated thatwidth 164 and/orheight 142 of the partition orwall 148 may be varied to increase or decrease the surface area of thecoating 140. For example, while thestent 100 is generally illustrated as thewalls 148 having aheight 142 approximately equal to a height of thestrut 136 with thecoating 140 disposed thereon, theheight 142 may be greater than or less than the height of thestrut 136 with thecoating 140 disposed thereon. It is further contemplated that the partitions orwalls 148 each have thesame height 142. It is contemplated that theheight 142 may vary uniformly, non-uniformly, in a patterned arrangement or eccentrically about the length and/or circumference of thestent 100. While the partition orwall 148 is illustrated as having a generally cubic rectangular shape, other shapes may be used, such as, but not limited, hemispherical, conical, pyramidal, etc. - It is contemplated that the volume of tissue that fills the voids of the
pockets 144 may be manipulated by changing a volume of thepockets 144 and/or the size of the walls partitions or 148. While thepockets 144 and partitions orwalls 148 are each illustrated as having generally uniform dimensions (e.g., are all approximately the same size, shape, and/or volume), thepockets 144 and/or partitions orwalls 148 need not all have the same dimensions. For example, somepockets 144 and/or partitions orwalls 148 may be larger than others. In some embodiments, one or more of thepockets 144 may include an opening, such as, but not limited to, an aperture or slit to allow for limited tissue ingrowth. Limited tissue ingrowth may further reduce migration of thestent 100 while still allowing for the removal of thestent 100 with little difficulty. Alternatively, or additionally, slits or apertures may be provided to allow for a peripheral vessel to drain into thelumen 150 or to create a drainage channel in thestent 100. In some cases, the physician may create the slits or apertures by cutting or punching through thepockets 144. -
FIG. 6A illustrates a partial cross-sectional view of a variation of theillustrative stent 100 ofFIG. 4 deployed in abody lumen 50 having avessel wall 52. InFIG. 6A , it can be seen that thepockets 144 may be formed having a generally arcuate shape, such as a generally spherical shape with a spherically concave radially outward facing surface and a spherically convex radially inwardly facing surface. The partitions orwalls 148 may extend radially outward from the spherically concave outward facing surface. - The stents, delivery systems, and the various components thereof, may be made from a metal, metal alloy, polymer (some examples of which are disclosed below), a metal-polymer composite, ceramics, combinations thereof, and the like, or other suitable material. Some examples of suitable metals and metal alloys include stainless steel, such as 304V, 304L, and 316LV stainless steel; mild steel; nickel-titanium alloy such as linear-elastic and/or super-elastic nitinol; other nickel alloys such as nickel-chromium-molybdenum alloys, nickel-copper alloys, nickel-cobalt-chromium-molybdenum alloys, nickel-molybdenum alloys, other nickel-chromium alloys, other nickel-molybdenum alloys, other nickel-cobalt alloys, other nickel-iron alloys, other nickel-copper alloys, other nickel-tungsten or tungsten alloys, and the like; cobalt-chromium alloys; cobalt-chromium-molybdenum alloys; platinum enriched stainless steel; titanium; combinations thereof; and the like; or any other suitable material.
- Some examples of suitable polymers for the stents or delivery systems may include polytetrafluoroethylene (PTFE), ethylene tetrafluoroethylene (ETFE), fluorinated ethylene propylene (FEP), polyoxymethylene (POM, for example, DELRIN® available from DuPont), polyether block ester, polyurethane (for example, Polyurethane polypropylene (PP), polyvinylchloride (PVC), polyether-ester (for example, ARNITEL® available from DSM Engineering Plastics), ether or ester based copolymers (for example, butylene/poly(alkylene ether) phthalate and/or other polyester elastomers such as HYTREL® available from DuPont), polyamide (for example, DURETHAN® available from Bayer or CRISTAMID® available from Elf Atochem), elastomeric polyamides, block polyamide/ethers, polyether block amide (PEBA, for example available under the trade name PEBAX®), ethylene vinyl acetate copolymers (EVA), silicones, polyethylene (PE), MARLEX® high-density polyethylene, MARLEX® low-density polyethylene, linear low density polyethylene (for example REXELL®), polyester, polybutylene terephthalate (PBT), polyethylene terephthalate (PET), polytrimethylene terephthalate, polyethylene naphthalate (PEN), polyetheretherketone (PEEK), polyimide (PI), polyetherimide (PEI), polyphenylene sulfide (PPS), polyphenylene oxide (PPO), poly paraphenylene terephthalamide (for example, KEVLAR®), polysulfone, nylon, nylon-12 (such as GRILAMID® available from EMS American Grilon), perfluoro(propyl vinyl ether) (PFA), ethylene vinyl alcohol, polyolefin, polystyrene, epoxy, polyvinylidene chloride (PVdC), poly(styrene-b-isobutylene-b-styrene) (for example, SIBS and/or SIBS 50A), polycarbonates, ionomers, biocompatible polymers, other suitable materials, or mixtures, combinations, copolymers thereof, polymer/metal composites, and the like.
- In at least some embodiments, portions or all of the stents or delivery systems may also be doped with, made of, or otherwise include a radiopaque material. Radiopaque materials are generally understood to be materials which are opaque to RF energy in the wavelength range spanning x-ray to gamma-ray (at thicknesses of <0.005″). These materials are capable of producing a relatively dark image on a fluoroscopy screen relative to the light image that non-radiopaque materials such as tissue produce. This relatively bright image aids the user of the stents or delivery systems in determining its location. Some examples of radiopaque materials can include, but are not limited to, gold, platinum, palladium, tantalum, tungsten alloy, polymer material loaded with a radiopaque filler, and the like. Additionally, other radiopaque marker bands and/or coils may also be incorporated into the design of the stents or delivery systems to achieve the same result.
- It should be understood that this disclosure is, in many respects, only illustrative. Changes may be made in details, particularly in matters of shape, size, and arrangement of steps without exceeding the scope of the disclosure. This may include, to the extent that it is appropriate, the use of any of the features of one example embodiment being used in other embodiments. The invention's scope is, of course, defined in the language in which the appended claims are expressed.
Claims (20)
1. A stent, the stent comprising:
an elongated tubular member comprising at least one strut forming a tubular wall having a plurality of cells extending through a thickness of the tubular wall, the elongated tubular member configured to move between a radially collapsed configuration and a radially expanded configuration; and
a coating disposed on the elongated tubular member and spanning the plurality of cells, the coating forming a pocket within at least some of the plurality of cells and extending radially inward of the tubular wall to define a void;
wherein the pockets are truncated pyramidal shaped, with four converging side walls and a radially inward base wall intersecting each of the four converging side walls;
wherein a radially outward facing surface of the base wall is spaced radially inwardly of a radially innermost extent of the tubular wall.
2. The stent of claim 1 , further comprising a partition positioned within at least some of the pockets, each partition extending radially outward from the radially outward facing surface of the base wall of its respective pocket and transecting the void.
3. The stent of claim 2 , wherein at least some of the partitions extend generally perpendicular to a central longitudinal axis of the elongated tubular member.
4. The stent of claim 2 , wherein at least some of the partitions extend generally parallel to a central longitudinal axis of the elongated tubular member.
5. The stent of claim 2 , wherein at least some of the partitions extend at an oblique angle relative to a central longitudinal axis of the elongated tubular member.
6. The stent of claim 2 , wherein a height of the partitions is approximately equal to a height of the at least one strut having the coating disposed thereon.
7. The stent of claim 2 , wherein the at least one strut forms a plurality of cross-over points.
8. The stent of claim 7 , wherein at least some of the partitions extend between adjacent cross-over points.
9. The stent of claim 2 , wherein at least one pocket includes two or more partitions.
10. The stent of claim 2 , wherein the coating and the partitions are formed as a single monolithic structure.
11. The stent of claim 1 , wherein the coating defines an entirety of a surface of a lumen extending longitudinally through the stent.
12. The stent of claim 1 , wherein at least some of the pockets include an aperture formed therethrough.
13. A stent, the stent comprising:
an elongated tubular member comprising at least one strut forming a tubular wall having a plurality of cells extending through a thickness of the tubular wall, the elongated tubular member configured to move between a radially collapsed configuration and a radially expanded configuration; and
a coating disposed on the elongated tubular member and spanning the plurality of cells, the coating forming a pocket within at least some of the plurality of cells and extending radially inward of the tubular wall to define a void;
wherein the pockets have a rhombus shaped cross-section, with four flat side walls intersecting a base wall;
wherein a radially outward facing surface of the base wall is spaced radially inwardly of a radially innermost extent of the tubular wall.
14. The stent of claim 13 , further comprising a partition positioned within at least some of the pockets, each partition extending radially outward from the radially outward facing surface of the base wall of its respective pocket and transecting the void.
15. The stent of claim 13 , wherein the coating and the partitions are formed as a single monolithic structure.
16. The stent of claim 13 , wherein at least some of the pockets include an aperture formed therethrough.
17. A stent, the stent comprising:
an elongated tubular member comprising at least one strut forming a tubular wall having a plurality of cells extending through a thickness of the tubular wall, each of the plurality of cells having a cross-sectional shape, the elongated tubular member configured to move between a radially collapsed configuration and a radially expanded configuration; and
a coating disposed on the elongated tubular member and spanning the plurality of cells, the coating forming a pocket within at least some of the plurality of cells and extending radially inward of the tubular wall to define a void;
wherein the pockets each have a cross-sectional shape that is the same as the cross-sectional shape of the plurality of cells, the pockets each including four converging side walls and a radially inward base wall intersecting each of the four converging side walls;
wherein a radially outward facing surface of the base wall is spaced radially inwardly of a radially innermost extent of the tubular wall.
18. The stent of claim 17 , wherein the cross-sectional shape of the plurality of cells is a diamond shape.
19. The stent of claim 17 , further comprising a partition positioned within at least some of the pockets, each partition extending radially outward from the radially outward facing surface of the base wall of its respective pocket and transecting the void.
20. The stent of claim 17 , wherein at least some of the pockets include an aperture formed therethrough.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18/446,903 US20230381001A1 (en) | 2020-01-13 | 2023-08-09 | Anti-migration stent |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202062960470P | 2020-01-13 | 2020-01-13 | |
US17/125,116 US11759341B2 (en) | 2020-01-13 | 2020-12-17 | Anti-migration stent |
US18/446,903 US20230381001A1 (en) | 2020-01-13 | 2023-08-09 | Anti-migration stent |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US17/125,116 Continuation US11759341B2 (en) | 2020-01-13 | 2020-12-17 | Anti-migration stent |
Publications (1)
Publication Number | Publication Date |
---|---|
US20230381001A1 true US20230381001A1 (en) | 2023-11-30 |
Family
ID=74187359
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US17/125,116 Active 2041-05-13 US11759341B2 (en) | 2020-01-13 | 2020-12-17 | Anti-migration stent |
US18/446,903 Pending US20230381001A1 (en) | 2020-01-13 | 2023-08-09 | Anti-migration stent |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US17/125,116 Active 2041-05-13 US11759341B2 (en) | 2020-01-13 | 2020-12-17 | Anti-migration stent |
Country Status (6)
Country | Link |
---|---|
US (2) | US11759341B2 (en) |
EP (1) | EP4090296A1 (en) |
JP (1) | JP7499339B2 (en) |
KR (1) | KR20220128410A (en) |
CN (1) | CN114938628A (en) |
WO (1) | WO2021146021A1 (en) |
Family Cites Families (80)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4994071A (en) | 1989-05-22 | 1991-02-19 | Cordis Corporation | Bifurcating stent apparatus and method |
US5674277A (en) | 1994-12-23 | 1997-10-07 | Willy Rusch Ag | Stent for placement in a body tube |
DE4446036C2 (en) | 1994-12-23 | 1999-06-02 | Ruesch Willy Ag | Placeholder for placement in a body tube |
US5591197A (en) | 1995-03-14 | 1997-01-07 | Advanced Cardiovascular Systems, Inc. | Expandable stent forming projecting barbs and method for deploying |
CA2171896C (en) | 1995-03-17 | 2007-05-15 | Scott C. Anderson | Multi-anchor stent |
NZ331269A (en) | 1996-04-10 | 2000-01-28 | Advanced Cardiovascular System | Expandable stent, its structural strength varying along its length |
DE69736676T2 (en) | 1996-11-04 | 2007-01-11 | Advanced Stent Technologies, Inc., Pleasanton | EXPERIENCED DOUBLE STAR |
DE69732229T2 (en) | 1997-07-17 | 2005-12-29 | Schneider (Europe) Gmbh | Stent and manufacturing process for it |
US6443972B1 (en) | 1997-11-19 | 2002-09-03 | Cordis Europa N.V. | Vascular filter |
US6506437B1 (en) | 2000-10-17 | 2003-01-14 | Advanced Cardiovascular Systems, Inc. | Methods of coating an implantable device having depots formed in a surface thereof |
GB2379996B (en) | 2001-06-05 | 2004-05-19 | Tayside Flow Technologies Ltd | Flow means |
WO2003009773A2 (en) | 2001-07-26 | 2003-02-06 | Alveolus Inc. | Removable stent and method of using the same |
DE10148185B4 (en) | 2001-09-28 | 2005-08-11 | Alveolus, Inc. | Instrument for implanting vascular prostheses |
US20060292206A1 (en) * | 2001-11-26 | 2006-12-28 | Kim Steven W | Devices and methods for treatment of vascular aneurysms |
US7060089B2 (en) | 2002-01-23 | 2006-06-13 | Boston Scientific Scimed, Inc. | Multi-layer stent |
EP1550477B1 (en) | 2002-08-23 | 2015-11-04 | National Cerebral and Cardiovascular Center | Stent and process for producing the same |
US20040093056A1 (en) | 2002-10-26 | 2004-05-13 | Johnson Lianw M. | Medical appliance delivery apparatus and method of use |
US7527644B2 (en) | 2002-11-05 | 2009-05-05 | Alveolus Inc. | Stent with geometry determinated functionality and method of making the same |
US7875068B2 (en) | 2002-11-05 | 2011-01-25 | Merit Medical Systems, Inc. | Removable biliary stent |
US7959671B2 (en) | 2002-11-05 | 2011-06-14 | Merit Medical Systems, Inc. | Differential covering and coating methods |
US7637942B2 (en) | 2002-11-05 | 2009-12-29 | Merit Medical Systems, Inc. | Coated stent with geometry determinated functionality and method of making the same |
US7637934B2 (en) | 2003-03-31 | 2009-12-29 | Merit Medical Systems, Inc. | Medical appliance optical delivery and deployment apparatus and method |
US7604660B2 (en) | 2003-05-01 | 2009-10-20 | Merit Medical Systems, Inc. | Bifurcated medical appliance delivery apparatus and method |
DE602004021613D1 (en) | 2003-09-30 | 2009-07-30 | Alveolus Inc | REMOVABLE STENT |
WO2005032410A2 (en) | 2003-09-30 | 2005-04-14 | Alveolus Inc. | Removable stent |
EP1684666A4 (en) * | 2003-10-14 | 2010-04-07 | James C Peacock Iii | Aneurysm treatment system and method |
US20050131515A1 (en) | 2003-12-16 | 2005-06-16 | Cully Edward H. | Removable stent-graft |
US8535366B2 (en) | 2004-01-08 | 2013-09-17 | Merit Medical Systems, Inc. | Implantable device delivery system handle and method of use |
US7854756B2 (en) | 2004-01-22 | 2010-12-21 | Boston Scientific Scimed, Inc. | Medical devices |
DE102004012981B4 (en) | 2004-03-16 | 2009-01-02 | Alveolus Inc. | stent |
CA2567296A1 (en) | 2004-05-20 | 2005-12-01 | Med Institute, Inc. | Enhanced biological fixation of grafts |
WO2006014383A1 (en) | 2004-07-02 | 2006-02-09 | Cook Incorporated | Stent having arcuate struts |
US7887579B2 (en) | 2004-09-29 | 2011-02-15 | Merit Medical Systems, Inc. | Active stent |
CA2585347A1 (en) | 2004-10-25 | 2006-05-04 | Alveolus, Inc. | Stent removal and repositioning aid and associated method |
US20070213810A1 (en) | 2005-03-14 | 2007-09-13 | Richard Newhauser | Segmented endoprosthesis |
WO2006108010A2 (en) | 2005-04-04 | 2006-10-12 | Burpee Materials Technology, Llc | Flexible stent |
DE102005016103B4 (en) | 2005-04-08 | 2014-10-09 | Merit Medical Systems, Inc. | Duodenumstent |
DE102005019649A1 (en) | 2005-04-26 | 2006-11-02 | Alveolus Inc. | Flexible stent for positioning in lumen of esophagus comprises tube and stabilization members defined circumferentially about tube, where each member extends inwardly in tube to define inner diameter that is less than inner diameter of tube |
EP1885288B1 (en) | 2005-05-13 | 2015-03-18 | Merit Medical Systems, Inc. | Drainage stent and associated method |
US7731654B2 (en) | 2005-05-13 | 2010-06-08 | Merit Medical Systems, Inc. | Delivery device with viewing window and associated method |
US20070005127A1 (en) | 2005-06-17 | 2007-01-04 | Peter Boekstegers | Hinged tissue implant and related methods and devices for delivering such an implant |
US7651520B2 (en) | 2006-05-30 | 2010-01-26 | Ostial Solutions, Llc | Means and method for the accurate placement of a stent at the ostium of an artery |
US7740791B2 (en) | 2006-06-30 | 2010-06-22 | Advanced Cardiovascular Systems, Inc. | Method of fabricating a stent with features by blow molding |
US8080053B2 (en) | 2006-08-01 | 2011-12-20 | Merit Medical Systems, Inc. | Stent, stent removal and repositioning device, and associated methods |
US8128679B2 (en) | 2007-05-23 | 2012-03-06 | Abbott Laboratories Vascular Enterprises Limited | Flexible stent with torque-absorbing connectors |
EP2167152B1 (en) * | 2007-06-13 | 2012-08-01 | Boston Scientific Scimed, Inc. | Anti-migration features and geometry for a shape memory polymer stent |
WO2009091899A2 (en) * | 2008-01-17 | 2009-07-23 | Boston Scientific Scimed, Inc. | Stent with anti-migration feature |
US7815673B2 (en) | 2008-04-01 | 2010-10-19 | Medtronic Vascular, Inc. | Double-walled stent system |
US20100256731A1 (en) | 2009-04-02 | 2010-10-07 | Mangiardi Eric K | Stent |
US8114147B2 (en) | 2008-06-16 | 2012-02-14 | Boston Scientific Scimed, Inc. | Continuous double layered stent for migration resistance |
US20100030321A1 (en) | 2008-07-29 | 2010-02-04 | Aga Medical Corporation | Medical device including corrugated braid and associated method |
US20100100170A1 (en) | 2008-10-22 | 2010-04-22 | Boston Scientific Scimed, Inc. | Shape memory tubular stent with grooves |
AU2010238636A1 (en) | 2009-04-24 | 2011-11-17 | Flexible Stenting Solutions, Inc. | Flexible devices |
EP2624791B1 (en) | 2010-10-08 | 2017-06-21 | Confluent Medical Technologies, Inc. | Alternating circumferential bridge stent design |
CA2818687C (en) | 2010-12-07 | 2020-04-28 | Merit Medical Systems, Inc. | Stent delivery systems and methods |
US20130018215A1 (en) | 2011-01-18 | 2013-01-17 | Merit Medical Systems, Inc. | Esophageal stent and methods for use of same |
JP6203639B2 (en) | 2011-01-28 | 2017-09-27 | メリット・メディカル・システムズ・インコーポレイテッドMerit Medical Systems,Inc. | Electrospun PTFE coated stent and method of use |
CN103547238B (en) | 2011-04-27 | 2016-01-20 | 百乐仕医疗器械有限公司 | Support |
US10285798B2 (en) | 2011-06-03 | 2019-05-14 | Merit Medical Systems, Inc. | Esophageal stent |
US8715334B2 (en) | 2011-07-14 | 2014-05-06 | Boston Scientific Scimed, Inc. | Anti-migration stent with quill filaments |
US20130103163A1 (en) | 2011-10-21 | 2013-04-25 | Merit Medical Systems, Inc. | Devices and methods for stenting an airway |
US20130103162A1 (en) | 2011-10-25 | 2013-04-25 | Kieran Costello | Coated stent |
US9681969B2 (en) | 2011-10-31 | 2017-06-20 | Merit Medical Systems, Inc. | Delivery systems and methods for sheathing and deploying an implantable device |
US8986368B2 (en) | 2011-10-31 | 2015-03-24 | Merit Medical Systems, Inc. | Esophageal stent with valve |
WO2013101667A1 (en) | 2011-12-29 | 2013-07-04 | Boston Scientific Scimed, Inc. | Stent with anti-migration features |
CA2856305C (en) | 2012-01-16 | 2017-01-10 | Merit Medical Systems, Inc. | Rotational spun material covered medical appliances and methods of manufacture |
US9526640B2 (en) * | 2013-08-18 | 2016-12-27 | Boston Scientific Scimed, Inc. | Anti-migration micropatterned stent coating |
EP2854718B1 (en) | 2012-06-05 | 2017-03-22 | Merit Medical Systems, Inc. | Esophageal stent |
WO2014010679A1 (en) | 2012-07-13 | 2014-01-16 | 株式会社パイオラックスメディカルデバイス | Stent |
US10507268B2 (en) | 2012-09-19 | 2019-12-17 | Merit Medical Systems, Inc. | Electrospun material covered medical appliances and methods of manufacture |
US9198999B2 (en) | 2012-09-21 | 2015-12-01 | Merit Medical Systems, Inc. | Drug-eluting rotational spun coatings and methods of use |
ES2901800T3 (en) | 2013-02-28 | 2022-03-23 | Boston Scient Scimed Inc | Medical devices for use in the biliary and/or pancreatic tract |
JP6473089B2 (en) | 2013-03-05 | 2019-02-20 | メリット・メディカル・システムズ・インコーポレイテッドMerit Medical Systems,Inc. | Reinforcing valve |
EP2967930B1 (en) | 2013-03-13 | 2018-11-28 | Boston Scientific Scimed, Inc. | Anti-migration tissue anchoring system for a fully covered stent |
JP2016515008A (en) | 2013-03-15 | 2016-05-26 | メリット・メディカル・システムズ・インコーポレーテッド | Esophageal stent |
EP3030195B1 (en) | 2013-08-07 | 2017-09-27 | Boston Scientific Scimed, Inc. | Silicone reflux valve for polymeric stents |
CN105705118B (en) | 2013-09-12 | 2018-03-30 | 波士顿科学国际有限公司 | Support with anti-displacement connector |
US10219921B2 (en) | 2014-10-02 | 2019-03-05 | Boston Scientific Scimed, Inc. | Controlled ingrowth feature for antimigration |
US10307273B2 (en) | 2015-03-03 | 2019-06-04 | Boston Scientific Scimed, Inc. | Stent with anti-migration features |
EP3476370B1 (en) | 2016-06-23 | 2023-02-15 | M.I.Tech Co., Ltd. | Multi-hole stent for digestive organs |
-
2020
- 2020-12-17 JP JP2022542688A patent/JP7499339B2/en active Active
- 2020-12-17 US US17/125,116 patent/US11759341B2/en active Active
- 2020-12-17 CN CN202080092763.7A patent/CN114938628A/en active Pending
- 2020-12-17 WO PCT/US2020/065583 patent/WO2021146021A1/en unknown
- 2020-12-17 EP EP20842616.3A patent/EP4090296A1/en active Pending
- 2020-12-17 KR KR1020227028138A patent/KR20220128410A/en active IP Right Grant
-
2023
- 2023-08-09 US US18/446,903 patent/US20230381001A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
EP4090296A1 (en) | 2022-11-23 |
KR20220128410A (en) | 2022-09-20 |
JP7499339B2 (en) | 2024-06-13 |
US20210212848A1 (en) | 2021-07-15 |
WO2021146021A1 (en) | 2021-07-22 |
CN114938628A (en) | 2022-08-23 |
JP2023510553A (en) | 2023-03-14 |
US11759341B2 (en) | 2023-09-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11986407B2 (en) | Stent | |
US11351045B2 (en) | Stent anchoring system | |
US10653510B2 (en) | Stent including displacement capabilities | |
US20210121306A1 (en) | Stent including anti-migration capabilities | |
US11759341B2 (en) | Anti-migration stent | |
US12029666B2 (en) | Stent anchoring system | |
US20240189123A1 (en) | Stent with self-adjusting anti-migration features | |
US20240164920A1 (en) | Stent with selective membrane coating | |
US12023265B2 (en) | Stent including anti-migration capabilities | |
US20200222212A1 (en) | Stent including anti-migration capabilities |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |